Evidence-Based Medicine Guidelines
Human recombinant activated protein C for severe sepsis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Human Recombinant Activated Protein C for Severe Sepsis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456040/all/Human_recombinant_activated_protein_C_for_severe_sepsis.
Human recombinant activated protein C for severe sepsis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456040/all/Human_recombinant_activated_protein_C_for_severe_sepsis. Accessed April 19, 2024.
Human recombinant activated protein C for severe sepsis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456040/all/Human_recombinant_activated_protein_C_for_severe_sepsis
Human Recombinant Activated Protein C for Severe Sepsis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456040/all/Human_recombinant_activated_protein_C_for_severe_sepsis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Human recombinant activated protein C for severe sepsis
ID - 456040
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456040/all/Human_recombinant_activated_protein_C_for_severe_sepsis
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
